• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2022, Vol. 24 ›› Issue (6): 710-715.DOI: 10.3969/j.issn.1671-2587.2022.06.006

• 临床输血 • 上一篇    下一篇

云南省地中海贫血儿童输血安全策略的研究*

陈蕊, 吕孟兴, 尹加忠, 沈经纬, 熊荣, 白云艳, 周文彪, 王旭, 杨琦, 屈柯暄   

  1. 650228 昆明市儿童医院,云南省儿童健康与疾病临床医学研究中心(陈蕊,吕孟兴,屈柯暄); 德宏州人民医院(尹加忠); 大理州人民医院(沈经纬); 文山市人民医院(熊荣); 西双版纳州勐海县人民医院(白云艳); 楚雄州人民医院(周文彪); 普洱市中心血站(王旭); 保山市人民医院(杨琦)
  • 收稿日期:2022-08-30 发布日期:2023-01-05
  • 通讯作者: 屈柯暄,副主任技师,主要从事儿科输血研究,(E-mail)qukexuan@etyy.cn。沈经纬,副主任技师,主要从事临床输血管理,(E-mail)sjw13987253876@163.com。王旭,主管技师,主要从事血液质量管理,(E-mail)812122545@qq.com。
  • 作者简介:陈蕊(1988-),女,主管技师,本科,主要从事儿科输血研究,(E-mail)471616613@qq.com。并列第一作者:尹加忠(1978-),男,副主任技师,本科,主要从事临床输血研究,(E-mail)1500370330@qq.com。并列第一作者:周文彪(1980-),男,副主任技师,本科,主要从事临床输血管理,(E-mail)18987838289@126.com。
  • 基金资助:
    *本课题受云南省昆明市卫生科技人才培养项目暨“十百千”工程(No.2021-SW(省)-024)、云南省儿童健康与疾病临床医学研究中心开放课题(No.2022-ETYY-YJ-09)、昆明市卫生健康委员会卫生科研课题(No.2022-06-04-003)资助

The Transfusion Management in Children with Thalassemia:Safety Strategies in Yunnan Province

CHEN Rui, LV Meng-xing, YIN Jia-zhong, et al   

  1. Kunming Children's Hospital, Clinical Medical, Kunming 650034
  • Received:2022-08-30 Published:2023-01-05

摘要: 目的 制定云南省地中海贫血儿童输血安全策略,探讨策略的可行性和安全性。方法 选取策略实施前(2012年~2016年)、后(2017年~2021年)云南省地中海贫血高发的8个地州市接受一次及以上输血治疗的地中海贫血儿童2 620例,比较输血安全策略实施前、后意外抗体阳性检出率和输血不良反应发生率。结果 策略实施后,意外抗体阳性检出率和输血不良反应发生率明显降低,意外抗体阳性检出率从33.62%降至7.64%,输血不良反应发生率从4.31%降至0.36%,差异有统计学意义(P<0.01)。。结论 云南省地中海贫血儿童输血安全策略科学、合理、有效,应对地中海贫血儿童常规进行ABO、RhCcDEe和MNSs血型抗原检测和意外抗体筛查,可预防性输注与患儿ABO、RhCcDEe和MNSs抗原分型一致的血液,确保输血治疗安全有效。

关键词: 云南, 地中海贫血儿童, 输血治疗, 输血安全策略

Abstract: Objective To explore the safe blood transfusion strategy for thalassemia in children in Yunnan Province. Methods A total of 2 620 children diagnosed with thalassemia who received once or repeated blood transfusions in eight cities with a high incidence of thalassemia in Yunnan Province before(from 2012 to 2016)and after (from 2017 to 2021) the implementation of the safe blood transfusion strategy were selected. The positive rate of screening antibodies and the incidence of adverse reactions in blood transfusion were compared. Results After the implementation of the strategy,the positive rate of screening antibodies and the incidence of adverse reactions in blood transfusion were significantly reduced. The positive rate of screening antibodies decreased from 33.62% to 7.64%,and the incidence of adverse reactions in blood transfusion decreased from 4.31% to 0.36%,and the differences were statistically significant(P<0.01). Conclusion The safe transfusion strategy is scientific,reasonable and effective. The detection of ABO,Rh-CcDEe and MNSs blood group antigen and screening antibodies should be performed in practice in children with thalassemia. Prophylactic ABO,Rh-CcDEe and MNSs antigen-matched blood is transfused to ensure the safety and effectiveness of transfusion therapy.

Key words: Yunnan, Thalassemia children, Transfusion therapy, Transfusion safety strategy

中图分类号: